KumbyAI is the AI-powered analyst that synthesizes news, identifies risks, and delivers actionable intelligence for quality and compliance professionals.
A real-time look at the news KumbyAI is analyzing right now.
Fierce Pharma
less than a minute ago
Shortly after initiating a separate recall tied to mislabeled pain medicine, Fresenius Kabi is yanking a batch of another product in the U.S.
Fierce Pharma
less than a minute ago
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.
Fierce Pharma
less than a minute ago
Snapchat is courting pharma marketers with a new ad format designed to support the disclosure needs of branded prescription drug campaigns.
Fierce Pharma
less than a minute ago
Arguing that the Defense Department might have misread the evidence and inflicted harm on the company, a federal judge has thrown WuXi AppTec a lifeline as the research and manufacturing services juggernaut fights its recent classification by the U.S. government as a Chinese military company.
Fierce Pharma
less than a minute ago
Despite their divergent second-quarter performance against consensus estimates, BridgeBio and Alnylam are now targeting the same population—first-line ATTR-CM patients—as the silencer-vs-stabilizer debate drags on.
Fierce Pharma
less than a minute ago
President Donald Trump signed an executive order Monday that calls for reducing the number of required vaccinations for children in a move that backs a revised immunization schedule pushed by the Department of Health and Human Services.